Misdiagnosis of autoimmune pancreatitis: A caution to clinicians

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1620-1623

  Gardner, Timothy B ^a,b   Levy, Michael J ^a   Takahashi, Naoki ^a   Smyrk, Thomas C ^a   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; RHEUMATOID FACTOR;

AUTOIMMUNE PANCREATITIS; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LYMPHOCYTIC INFILTRATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREATOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT PLANNING;

ABDOMINAL PAIN; ADRENAL CORTEX HORMONES; AUTOIMMUNE DISEASES; AWARENESS; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 67650463143     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.89     Document Type: Short Survey

References (18)

1. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007;42(Suppl 18):39-41.
2. Kamisawa T. IgG4-related sclerosing disease. Intern Med 2006;45:125-6.
3. Kim KP, Kim MH, Lee SS et al. Autoimmune pancreatitis: it may be a worldwide entity. Gastroenterology 2004;126:1214.
4. Yoshida K, Toki F, Takeuchi T et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8.
5. Sarles H, Sarles JC, Muratore R et al. Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease? Am J Dig Dis 1961;6:688-98.
6. Kamisawa T, Nakajima H, Egawa N et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperi-toneal fibrosis with lymphadenopathy Pancreatology 2006;6:132-7.
7. Okazaki K. Autoimmune pancreatitis: etiology pathogenesis, clinical findings and treatment. The Japanese experience. JOP 2005;6(Suppl l):89-96.
8. Chari ST, Smyrk TC, Levy MJ et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-6.
9. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am 2008;37:439-60.
10. Yadav D, Notahara K, Smyrk TC et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol 2003;1:129-35.
11. Pearson RK, Longnecker DS, Chari ST et al. Controversies in clinical pan-creatology: autoimmune pancreatitis: does it exist? Pancreas 2003;27:1-13.
12. Choi EK, Kim MH, Kim JC et al. The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory? Pancreas 2006;33:13-9.
13. Kim KP, Kim MH, Kim JC et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006;12:2487-96.
14. Otsuki M, Chung JB, Okazaki K et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol 2008;43:403-8.
15. Ghazale A, Chari ST, Smyrk TC et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-53.
16. Hosoda H, Okawa-Takatsuji M, Shinmura W et al. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase antibody. Pancreas 2008;31:el-7.
17. Manfredi R, Graziani, Cicero C et al. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008;247:435-43.
18. Moon S-H, Kim M-H, Park DH et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704-12.